GeoPharma reports 4th-qtr and FY results

USA-based GeoPharma fell into loss for the full year and three months ending March 31, 2008, due to increasing marketing costs.

The firm generated revenue of $23.9 million during its fourth quarter, a 66% rise on the same period of 2007. Still, it recorded a net loss of $2.8 million versus a net profit of $534,000 in the year-before period.

Revenue for the 2008 full year was $57.9 million, a minor decrease of 3% year-on-year. R&D costs increased slightly to $1.6 million vs $1.5 million, but selling, general and administrative costs rose 33% to $20.8 million vs 2007. Ultimately, this left the firm with a net loss of $7.4 million for the year, or 59 cents per share, vs a net profit of $2.2 million in the year before.